Literature DB >> 18391872

Echocardiographic assessment of the incidence of mechanical complications during the early phase of myocardial infarction in the reperfusion era: a French multicentre prospective registry.

P Gueret1, K Khalife, Y Jobic, E Fillipi, K Isaaz, S Tassan-Mangina, C Baixas, P Motreff, C Meune.   

Abstract

BACKGROUND: Since the early reports on the incidence of mechanical complications of acute myocardial infarction (AMI) assessed by echocardiography published in the 1980s, the management of patients with AMI has changed considerably, in particular with the progressive development of early revascularisation.
METHODS: The aim of this multicentre study was to assess the incidence of mechanical complications of AMI in the reperfusion era. Nine-hundred and eight consecutive patients were included. Echocardiography was performed on admission and at discharge. Seventy-eight percent of patients were revascularised at the acute phase.
RESULTS: The following incidence rates of mechanical complications were observed: mitral regurgitation 28%, secondary to left ventricular (LV) remodelling (43%) or papillary muscle dysfunction (57%); pericardial effusion 6.6%, more frequent after anterior AMI and associated with a lower ejection fraction (EF); LV thrombus 2.4%, mainly after anterior AMI and associated with a lower EF (38+/-10% vs. 48+/-12%; p<0.001); early infarct expansion 4%; septal rupture 0.6%; and acute free wall rupture 0.8%. The following factors were independently associated with the occurrence of mechanical complications by multivariate logistic regression analysis: lack of early revascularisation (OR 3.48, 95%CI 1.36-8.95; p<0.001), LV-EF<50% (OR 1.95, 95%CI 1.42-2.67; p<0.001), Killip class>II (OR 1.91, 95%CI 1.27-2.87; p<0.002) and age > or =70 years (OR 1.42, 95%CI 1.03-1.97; p<0.03).
CONCLUSION: This study demonstrates the favourable prognostic influence of early revascularisation as shown by the low incidence of mechanical complications after AMI, and underlines the persistent relationship between the development of these complications and depressed LV function.

Entities:  

Mesh:

Year:  2008        PMID: 18391872     DOI: 10.1016/s1875-2136(08)70254-7

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  6 in total

1.  Healing a Broken Heart: a Case Report of Left Ventricular Free Wall Rupture and Review of the Literature.

Authors:  Roxana Oana Darabont; Alexandru Vasilescu; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2016-12

2.  Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction.

Authors:  Wobbe Bouma; Hendrik M Willemsen; Chris P H Lexis; Niek H Prakken; Erik Lipsic; Dirk J van Veldhuisen; Massimo A Mariani; Pim van der Harst; Iwan C C van der Horst
Journal:  Clin Res Cardiol       Date:  2016-06-08       Impact factor: 5.460

3.  Mechanical complications of ST segment elevation myocardial infarction: are they tangible?

Authors:  Seong Huan Choi; Sung Woo Kwon
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

4.  The role of echocardiography in coronary artery disease and acute myocardial infarction.

Authors:  Maryam Esmaeilzadeh; Mozhgan Parsaee; Majid Maleki
Journal:  J Tehran Heart Cent       Date:  2013-01-08

Review 5.  Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.

Authors:  Abdulla A Damluji; Sean van Diepen; Jason N Katz; Venu Menon; Jacqueline E Tamis-Holland; Marie Bakitas; Mauricio G Cohen; Leora B Balsam; Joanna Chikwe
Journal:  Circulation       Date:  2021-06-15       Impact factor: 39.918

6.  Blood group A: a risk factor for heart rupture after acute myocardial infarction.

Authors:  Yuan Fu; Mulei Chen; Hao Sun; Zongsheng Guo; Yuanfeng Gao; Xinchun Yang; Kuibao Li; Lefeng Wang
Journal:  BMC Cardiovasc Disord       Date:  2020-11-03       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.